Back

miRISC inhibition causes mitotic defects and synergizes with genotoxic agents in cancers

Zhang, M.; Jiao, Z.; Cendon Florez., Y.; Lessel, I.; Yao, M. A.; Weigl, M.; Ozimek., M.; Dogruluk, T.; Chen, K.; Fernandez, K. C.; Vinagolu, R. K.; Popow, O.; Paulo, J. A.; Pradella, D.; Mishra, T.; Mastroleo, C.; Delgado., J. I.; DAmico, F. E.; Cavalieri, V.; Morris, C. D.; Tsou, M.-F. B.; Haigis, K. M.; Chauduri, J.; Benezra, R.; Vidigal, J. A.; Lessel, D.; Ventura, A.; La Rocca, G.

2025-12-15 cancer biology
10.64898/2025.12.12.693984 bioRxiv
Show abstract

Although individual microRNAs (miRNAs) can have tumorigenic or tumor-suppressive properties, their overall role in cancer remains controversial. Here, we show that cancer tissues and cell lines are characterized by preferential accumulation of the high-molecular-weight miRNA-induced silencing complex (HMWR), the functionally active form of the effector complex responsible for miRNA-mediated gene repression. Experimentally induced disassembly of the HMWR impairs the growth of human tumor xenografts and of autochthonous tumors in mouse models of human cancer in vivo. Furthermore, disassembly of the HMWR increases chromosome mis-segregation, which synergized with genotoxic agents to potentiate cancer cell vulnerability and improve therapeutic response. These findings suggest pharmacologic inhibition of HMWR as a novel anti-cancer strategy.

Matching journals

The top 5 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.